HUNAN FANGSHENG PHARMACEUTICAL CO., LTD.

All News Hunan Fangsheng Pharmaceutical Co., Ltd.

Equities

603998

CNE100001VG6

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
11.84 ^CNY	+0.17%		-0.84%	+8.03%

04-19	Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-10	Fangsheng Pharma's Factories Pass GMP Inspection	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
Fangsheng Pharma's Factories Pass GMP Inspection	04-10	MT
Fangsheng Pharma Gets 12.1 Million Yuan in Government Grants in January-March	04-08	MT
Fangsheng Pharma Withdraws Drug Registration Application For Headache Treatment	12-01	MT
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	20/04/23	CI
Fangsheng Pharma's Drugs Placed in 2022 Chinese Drug Catalogue	20/01/23	MT
Hunan Fangsheng Pharmaceutical Sees Up to 357% Surge in 2022 Profit; Shares Jump 3%	19/01/23	MT
Hunan Fangsheng Pharma Unit to Resume Work After Leakage Forces Suspension	15/12/22	MT
Hunan Fangsheng Pharmaceutical's Chinese Medicine Extraction Line Passes Regulatory Inspection	06/12/22	MT
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 269.999999 million in funding	03/03/22	CI
Hunan Fangsheng Pharmaceutical Co., Ltd. announced a financing transaction	03/03/22	CI
Hunan Fangsheng Ruixin Pharmaceutical Co., Ltd. announced that it expects to receive CNY 160 million in funding from Hunan Fangsheng Pharmaceutical Co., Ltd., Changsha Xingchen Kangrui Venture Capital Partnership Enterprise (Limited Partnership), and another investor	29/12/21	CI
China shares end lower as rising local COVID-19 cases drag consumer firms	27/12/21	RE
Guo Jianjun agree to acquire 50% stake in Hunan Hengxing Pharmaceutical Technology Co., Ltd. from Hunan Fangsheng Pharmaceutical Co., Ltd. for CNY 9.4 million.	17/12/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Hunan Fangsheng Pharmaceutical Co., Ltd.

Equities

603998

CNE100001VG6

All News

Filters